Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection

Study Title
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ֳŸ-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Teva Identifier
LAQ-MS-306 | 2013-002082-19
ClinicalTrials.gov Identifier
NCT01975298
Study Status
Withdrawn
Trial Condition(s)
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: Laquinimod | Drug: Avonexֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 55 Years
Trial Duration
01/01/2014 - 03/01/2014
Phase
Phase 3

Study Type

Interventional